Download MendeleyDiscovery of S-[5-Amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]-methanone (RO3201195), and Orally Bioavailable and Highly Selective Inhibitor of p38 Map Kinase
Goldstein, D.M., Alfredson, T.A., Bertrand, J., Browner, M.F., Clifford, K., Dalrymple, S., Dunn, J., Freire-Moare, J., Harris, S.F., Labadie, S.S., La Fargue, J., Lapierre, J.M., Larrabee, S., Li, F., Papp, E., McWeeney, D., Ramesha, C., Roberts, R., Rotstein, D., San Pablo, B., Sjogren, E., So, O.Y., Talamas, F.X., Tao, W., Trejo, A., Villasenor, A., Welch, M., Welch, T., Weller, P., Whiteley, P.E., Young, K., Zipfel, S.(2006) J Med Chem 49: 1562-1575
- PubMed: 16509574
- DOI: https://doi.org/10.1021/jm050736c
- Primary Citation of Related Structures:
2GFS - PubMed Abstract:
A novel class of highly selective inhibitors of p38 MAP kinase was discovered from high throughput screening. The synthesis and optimization of a series of 5-amino-N-phenyl-1H-pyrazol-4-yl-3-phenylmethanones is described. An X-ray crystal structure of this series bound in the ATP binding pocket of unphosphorylated p38alpha established the presence of a unique hydrogen bond between the exocyclic amine of the inhibitor and threonine 106 which likely contributes to the selectivity for p38 ...
